Clinical Trials Logo

Severe Uncontrolled Asthma clinical trials

View clinical trials related to Severe Uncontrolled Asthma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04305405 Completed - Clinical trials for Severe Uncontrolled Asthma

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

TATE
Start date: November 21, 2019
Phase: Phase 3
Study type: Interventional

This study will evaluate the PK, PD and long-term safety of Benralizumab administered subcutaneously in 30 children aged 6 to 11 years with severe eosinophilic asthma. Up to an additional 3 Japanese patients aged 12 to 14 years will be enrolled to meet local regulatory requirements.

NCT ID: NCT04200326 Completed - Clinical trials for Severe Uncontrolled Asthma

Real-life First Dose Effect of Fasenra in Patients With Severe Uncontrolled Asthma

TWINKLE
Start date: December 20, 2019
Phase:
Study type: Observational

This pilot study will use novel technologies to collect information about the patient experience before and early after starting Fasenra (benralizumab) as standard of care for severe uncontrolled asthma in a real-world setting, to determine how the experience changes over time. Any detection of an early, subjective first-dose effect in this pilot study will be further validated in a larger follow-up study.